Paper32927872
A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided.
Paszkiewicz RL and 8 others. Int J Mol Sci, 2020. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided. Papers, record 32927872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32927872
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adipocytes | Major topic |
| Lipolysis | Major topic |
| Morpholines | Major topic |
| Oxygen Consumption | Major topic |
| Pyrazoles | Major topic |
| Receptor, Cannabinoid, CB1 | Major topic |
| 3T3 Cells | |
| Animals | |
| Drug Evaluation, Preclinical | |
| Mice | |
| Mitochondria | |
| Obesity |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK027619 | NIDDK NIH HHS | United States | R01DK027619 | PubMed | NIH RePORTER |
| R01 DK029867 | NIDDK NIH HHS | United States | R01DK029867 | PubMed | NIH RePORTER |
| R01-DK029867 | NIH HHS | United States | R01DK029867 | PubMed | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 33922401 | Correction: Paszkiewicz et al. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting That Central Effects Can Be Avoided. Int. J. Mol. Sci. 2020, 21, 6639. | https://conductscience.org/library/papers/33922401 |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29158541 | Dysregulation of mitochondrial function and biogenesis modulators in adipose tissue of obese children. | Int J Obes (Lond) | 2018 | https://conductscience.org/library/papers/29158541 | PubMed |
| 2 | 30568302 | Thermal stress induces glycolytic beige fat formation via a myogenic state. | Nature | 2019 | https://conductscience.org/library/papers/30568302 | PubMed |
| 3 | 8371057 | Fat cell adrenergic receptors and the control of white and brown fat cell function. | J Lipid Res | 1993 | https://conductscience.org/library/papers/8371057 | PubMed |
| 4 | 30219068 | Localization of fat depots and cardiovascular risk. | Lipids Health Dis | 2018 | https://conductscience.org/library/papers/30219068 | PubMed |
| 5 | 19366874 | Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs. | Am J Physiol Endocrinol Metab | 2009 | https://conductscience.org/library/papers/19366874 | PubMed |
| 6 | 26390217 | Isoproterenol Increases Uncoupling, Glycolysis, and Markers of Beiging in Mature 3T3-L1 Adipocytes. | PLoS One | 2015 | https://conductscience.org/library/papers/26390217 | PubMed |
| 7 | 15855325 | Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. | Diabetes | 2005 | https://conductscience.org/library/papers/15855325 | PubMed |
| 8 | 19578688 | The psychiatric side-effects of rimonabant. | Braz J Psychiatry | 2009 | https://conductscience.org/library/papers/19578688 | PubMed |
| 9 | 16009704 | The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. | FASEB J | 2005 | https://conductscience.org/library/papers/16009704 | PubMed |
| 10 | 22728333 | β(1) Adrenergic receptor is key to cold- and diet-induced thermogenesis in mice. | J Endocrinol | 2012 | https://conductscience.org/library/papers/22728333 | PubMed |
| 11 | 15836887 | Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. | Lancet | 2005 | https://conductscience.org/library/papers/15836887 | PubMed |
| 12 | 15131120 | Role of insulin action and cell size on protein expression patterns in adipocytes. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15131120 | PubMed |
| 13 | 24809334 | Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis. | J Cell Physiol | 2014 | https://conductscience.org/library/papers/24809334 | PubMed |
| 14 | 27345961 | Sarcolipin knockout mice fed a high-fat diet exhibit altered indices of adipose tissue inflammation and remodeling. | Obesity (Silver Spring) | 2016 | https://conductscience.org/library/papers/27345961 | PubMed |
| 15 | 31161155 | Ablation of adipocyte creatine transport impairs thermogenesis and causes diet-induced obesity. | Nat Metab | 2019 | https://conductscience.org/library/papers/31161155 | PubMed |
| 16 | 19339685 | Transcriptional control of brown adipocyte development and physiological function--of mice and men. | Genes Dev | 2009 | https://conductscience.org/library/papers/19339685 | PubMed |
| 17 | 29615900 | Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29615900 | PubMed |
| 18 | 28704952 | The Inhibitory Effect of Tartary Buckwheat Extracts on Adipogenesis and Inflammatory Response. | Molecules | 2017 | https://conductscience.org/library/papers/28704952 | PubMed |
| 19 | 17526015 | Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. | Hepatology | 2007 | https://conductscience.org/library/papers/17526015 | PubMed |
| 20 | 20880401 | A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/20880401 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42559446 | Tissue-specific roles of monoacylglycerol (MAG) in metabolic diseases. | Immunometabolism (Cobham) | 2026 | https://conductscience.org/library/papers/42559446 | PubMed |
| 39512900 | The impact of cannabinoid receptor 1 absence on mouse liver mitochondria homeostasis: insight into mitochondrial unfolded protein response. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39512900 | PubMed |
| 39273484 | Investigating the Role of Cannabinoid Type 1 Receptors in Vascular Function and Remodeling in a Hypercholesterolemic Mouse Model with Low-Density Lipoprotein-Cannabinoid Type 1 Receptor Double Knockout Animals. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273484 | PubMed |
| 36767008 | Pharmacological Support for the Treatment of Obesity-Present and Future. | Healthcare (Basel) | 2023 | https://conductscience.org/library/papers/36767008 | PubMed |
| 35063024 | The cannabinoid receptor I (CB1) enhanced the osteogenic differentiation of BMSCs by rescue impaired mitochondrial metabolism function under inflammatory condition. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35063024 | PubMed |
| 34500853 | CB1 Cannabinoid Receptor Signaling and Biased Signaling. | Molecules | 2021 | https://conductscience.org/library/papers/34500853 | PubMed |
| 34434170 | Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34434170 | PubMed |
| 33922401 | Correction: Paszkiewicz et al. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting That Central Effects Can Be Avoided. Int. J. Mol. Sci. 2020, 21, 6639. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33922401 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32927872
GET https://conductscience.org/api/papers/v1/32927872/references?page=2